Homelife sciences

life sciences

EyePoint Investor Alert

EyePoint Investor Alert

December 1, 2022

Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting

Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting

December 1, 2022

Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022

Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022

December 1, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, TALO, SSNT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, TALO, SSNT

December 1, 2022

DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for EIGR, TSP, and UIS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

December 1, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

December 1, 2022

BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics

BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics

December 1, 2022

Regeneron’s (REGN) sBLA for Evkeeza Gets FDA Priority Review

Regeneron’s (REGN) sBLA for Evkeeza Gets FDA Priority Review

December 1, 2022

Eloxx Pharmaceuticals Announces Reverse Stock Split Effective

Eloxx Pharmaceuticals Announces Reverse Stock Split Effective

December 1, 2022

Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388

Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388

December 1, 2022

« 1 … 20 21 22 23 24 … 557 »